Dr. Michael Sofia and Me Meeting the Man himself! The Sovaldi magician what I call him, is something I will cherish for lifetime. Listening to his presentation on Gilead was amazing. He in his presentation clearly justified that Sovaldi pricing is not justifiable! The Drug curing the patient is priceless and nothing less than that….
Read More
Presenting at Academic of Business research conference was amazing! Presenting on the shift of Clinical trials from North America and western Europe to other countries was a great experience. People response to the outcome was truly amazing. Question and Answer session at the end was fruitful. Moreover, understanding and listening to the new concepts of…
Read More
I successfully completed my iLead Leadership Series! It was fun and great learning experience. I figured out that everyone has a leader in them we just have our own unique ways to experience that! iLead made me aware that i believe in my unique ideas and have courage to express it where ever required!
Read More
My Research poster was presented on the Research day at USP. It was a great experience! Particularly when people found the topic interesting and asked questions and discussed their views. Picture below my certificate is with my advisor Dr. Harold Glass and my research poster. Its all been possible because of him. Topic of my…
Read More
Sun Pharma to buy Ranbaxy for $4.2Billion. This merger will make the combo largest manufacturer in India and 5th largest generic manufacturer in the world. Merger looks like a boon to the dying reputation of Ranbaxy as it give a new opportunity to grow in around 65countries. Personally, I feel sorry for the company which…
Read More
This partnership is going to help NouroVive drugs to treat acute cardiovascular and neurological conditions to market! NouroVive is already working on a project with inVentiv for about a year now on regulatory consultant project woth Paragon Rx. inVentiv offers a unique service that runs from early-stage clincal development to Full global commercialization. inVentiv is…
Read More
Read about Dr.Kessler, his efforts to change the way FDA worked are were tremendous. He was one fearless personality whoes non political behaviour and strong ethical views helped American live a much healthier life! Top three things he did were 1)speeding up of new drug approval process 2) Mandating detailed nutritional information on the label…
Read More
Organizing Basketball event for the Graduate students! Seems fun…Learned many business skills like negotiation, time management, project planning and most importantly coordination with various authorities!! I guess every activity teaches you something..
Read More
Some funny interesting cartoons conveying recent Pharmaceutical conditions…
Read More
The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Takeda Pharmaceutical’s new drug application (NDA) of Adcetris (brentuximab vedotin) 50mg intended to treat patients with CD30 positive relapsed or refractory hodgkin lymphoma (HL) or relapsed or refractory anaplastic large cell lymphoma (ALCL). Takeda head of the Oncology Therapeutic Area Unit Michael Vasconcelles said,…
Read More